Clinical Trials Logo

Clinical Trial Summary

Nested within the SwissPrEPared Program, the "SwissPrEPared Study" - a large, multicentric, nation-wide cohort study - aims to longitudinally follow individuals asking for PrEP prescription over a period of 3 years.


Clinical Trial Description

The main aims of the study will be: 1. To obtain epidemiological data on individuals asking for PrEP in Switzerland. We are particularly interested in: - Determining the extent of PrEP use in Switzerland; - Assessing and monitoring the occurrence of sexually transmitted infections (STIs) in this particular population. 2. To assess sexual health and sexual well-being in individuals asking for PrEP using a questionnaire specifically designed for the SwissPrEPared program. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03893188
Study type Observational
Source University of Zurich
Contact Jan Fehr, Prof.
Phone +41 44 634 46 11
Email jan.fehr@usz.ch
Status Recruiting
Phase
Start date April 10, 2019
Completion date March 2030

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04754139 - A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population N/A
Completed NCT02074891 - Sustainable Healthcenter Implementation PrEP Pilot Study
Completed NCT04424524 - Streamlining the Efficiency of PrEP Implementation
Completed NCT04652700 - Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024) Phase 3